Sputtr.com | Alternative Search Engine

Oseltamivir

Emergency Use Authorization (EUA) Review - Oseltamivir ...

Emergency Use Authorization (EUA) Review Oseltamivir Phosphate for Swine Influenza A Identifying Information: • Trade name: Tamiflu • Manufacturer: Roche Laboratories (NDA 21087 & 21246) • Established name: oseltamivir phosphate • Formulations: capsules 30 mg, 45 mg, and 75 mg powder for ...

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...

TAMIFLU® (oseltamivir phosphate) capsules TAMIFLU® (oseltamivir phosphate) for oral suspension Initial U.S. Approval: 1999

TAMIFLU™ (oseltamivir phosphate)

NDA 21-087/S-005 NDA 21-087/S-006 NDA 21-246/S-001 Page 3 TAMIFLU™ (oseltamivir phosphate) CAPSULES AND FOR ORAL SUSPENSION DESCRIPTION: TAMIFLU (oseltamivir phosphate) is available as a capsule containing 75 mg oseltamivir for oral use, in the form of oseltamivir phosphate, and as a powder ...

Tamiflu (oseltamivir phosphate) Capsules and Oral Solution

TAMIFLU (oseltamivir phosphate) CAPSULES AND FOR ORAL SUSPENSION Tamiflu (oseltamivir phosphate) Capsules and Oral Solution

Oseltamivir, amantadine (review) and zanamivir for the ...

NICE technology appraisal guidance 158 Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza (including a review of NICE technology appraisal guidance 67) Ordering information You can download the following documents from www.nice.org.uk/TA158 • The full guidance (this document).

Oseltamivir 75 mg (as phosphate) Capsules (Cipla Ltd.)

Oseltamivir Capsules 75 mg WHOPAR part 6 06/2009, version 1.0 (Cipla Ltd.), IN001 SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Oseltamivir Capsules 75 mg* Manufacturer of Prequalified Product: Cipla Ltd. Plot No .S-103 − S-105, S-107 −S-112, L-147,L-147-1 Verna ...

Pandemic (H1N1) 2009 Virus Infections,

Page 1 of 8 . DOI: http://dx.doi.org/10.3201/eid1802.111466 . Suggested citation for this article: Storms AD, Gubareva LV, Su S, Wheeling JT, OkomoAdhiambo M, Pan C-Y, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010– 11.

ANALYTICAL METHODOLOGIES FOR THE DETERMINATION OF OSELTAMIVIR

ISSN: 0975-8585 July - September 2010 RJPBCS Volume 1 Issue 3 Page No. 368 Research Journal of Pharmaceutical, Biological and Chemical Sciences ANALYTICAL METHODOLOGIES FOR THE DETERMINATION OF OSELTAMIVIR M. Espinosa Bosch a, C. Bosch Ojeda b, A. J. Ruiz Sánchez c, F ...

Mutations I117V and I117M and Oseltamivir Sensitivity of ...

Page 1 of 9 DOI: http://dx.doi.org/10.3201/eid1801.111079 Suggested citation for this article : Hurt AC, Leang SK, Speers DJ, Barr IG, Maurer-Stroh S. Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.

Guidelines for the establishment and use of the

2 Contents 1. Background 2. Pandemic preparedness strategies and role of antivirals 3. Why oseltamivir stockpiling is needed? 4. Establishing and managing stockpile 5.